Business

Announcement on Voluntary Disclosure of the Receipt of the Drug Clinical Trial Approval Notice for Product SCT640C by a Holding Subsidiary

Announcement on Voluntary Disclosure of the Receipt of the Drug Clinical Trial Approval Notice for Product SCT640C by a Holding Subsidiary

articleSinocelltech Group Limited Class AJuly 24, 20255/news/announcement-on-voluntary-disclosure-of-the-receipt-of-the-drug-clinical-trial-approval-notice-for-product-sct640c-by-a-holding-subsidiary
Announcement on Voluntary Disclosure of the Receipt of the Drug Clinical Trial Approval Notice for Product SCT640C by a Holding Subsidiary

About this update from Sinocelltech Group Limited Class A

Announcement on Voluntary Disclosure of the Receipt of the Drug Clinical Trial Approval Notice for Product SCT640C by a Holding SubsidiaryThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinocelltech Group Limited Class A